Dr. Daniel Meram, MD

Dr. Meram practices at IHA Bloomfield Primary Care in Ann Arbor, Michigan.

Dr. Meram's NPI, 1215354493, was assigned on March 25, 2014. Dr. Meram holds Michigan license 4301104944.

Dr. Meram's primary practice is IHA Bloomfield Primary Care, at 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 in Washtenaw County. The practice phone is (248) 836-0040.

Dr. Meram's primary practice is IHA Bloomfield Primary Care in Ann Arbor, Michigan. Dr. Meram is also affiliated with Trinity Health Oakland Hospital. The medical group on file is Trinity Health IHA Medical Group. Dmand AI also links Dr. Meram to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meram practices, 4 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Meram's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Meram is licensed in Michigan.

CMS data shows 473 Medicare services from Dr. Meram across 11 procedure codes in 2024, for 215 Medicare patients. Medicare paid $37,052 for them. Every service was in an office.

CMS counts 215 Medicare patients who saw Dr. Meram in 2024. The largest group is 65 to 74, with 89 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meram's median patient age at 52, with 46% women.

In 2024, Dr. Meram wrote 3,321 Medicare Part D claims for 366 patients. 88% of them were for generic drugs. CMS names the drug for 2,659 of them, across 72 drugs with 11 or more claims each, at $192,140 in total drug cost. In 2023, CMS named 2,335 claims across 67 drugs.

Dr. Meram accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meram as offering telehealth.

CMS Open Payments shows 7 general payments to Dr. Meram from 6 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Dynavax Technologies Corporation paid the most, $40.